EWSR1 and Ewing sarcoma: In accordance with the literature [24], YK-4-279 and Nutlin-3 showed synergistic activity against the EWS/FLI1-driven Ewing sarcoma model FP-BH despite harboring wild-type p53 (Supplementary Figure S5C).